| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5498059 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 9 Pages |
Abstract
TomoTherapy provided better locoregional control and cancer-specific survival than RapidArc treatment, with fewer salivary disorders. No significant difference was shown in progression-free and overall survival. These results should be explored in a randomized trial.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jean-Emmanuel MD, MSc, Sophie MD, Pascal MD, PhD, Magali MSc, Marius MSc, Pierre MD, Bernard MD, Marc MD, Etienne MD, Michel MD, Valentin MD, PhD, Enrique MD, Georges MD, PhD, Hinda MD, Stephanie MD, PhD, Lionel PhD, HDR, Philippe MD, PhD,